1. Home
  2. XBIO vs IPDN Comparison

XBIO vs IPDN Comparison

Compare XBIO & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • IPDN
  • Stock Information
  • Founded
  • XBIO N/A
  • IPDN 2003
  • Country
  • XBIO United States
  • IPDN United States
  • Employees
  • XBIO N/A
  • IPDN N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • IPDN EDP Services
  • Sector
  • XBIO Health Care
  • IPDN Technology
  • Exchange
  • XBIO Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • XBIO 4.2M
  • IPDN 4.3M
  • IPO Year
  • XBIO N/A
  • IPDN 2013
  • Fundamental
  • Price
  • XBIO $2.91
  • IPDN $1.53
  • Analyst Decision
  • XBIO Hold
  • IPDN
  • Analyst Count
  • XBIO 1
  • IPDN 0
  • Target Price
  • XBIO N/A
  • IPDN N/A
  • AVG Volume (30 Days)
  • XBIO 9.5K
  • IPDN 38.9K
  • Earning Date
  • XBIO 05-13-2025
  • IPDN 05-14-2025
  • Dividend Yield
  • XBIO N/A
  • IPDN N/A
  • EPS Growth
  • XBIO N/A
  • IPDN N/A
  • EPS
  • XBIO N/A
  • IPDN N/A
  • Revenue
  • XBIO $2,582,728.00
  • IPDN $6,508,349.00
  • Revenue This Year
  • XBIO $14.23
  • IPDN N/A
  • Revenue Next Year
  • XBIO N/A
  • IPDN N/A
  • P/E Ratio
  • XBIO N/A
  • IPDN N/A
  • Revenue Growth
  • XBIO 5.63
  • IPDN N/A
  • 52 Week Low
  • XBIO $2.20
  • IPDN $0.97
  • 52 Week High
  • XBIO $5.20
  • IPDN $11.70
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 49.56
  • IPDN 44.92
  • Support Level
  • XBIO $2.78
  • IPDN $1.65
  • Resistance Level
  • XBIO $3.22
  • IPDN $1.93
  • Average True Range (ATR)
  • XBIO 0.24
  • IPDN 0.17
  • MACD
  • XBIO 0.03
  • IPDN 0.03
  • Stochastic Oscillator
  • XBIO 34.16
  • IPDN 28.57

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.

Share on Social Networks: